Journey Medical Corp (DERM) Operating cash flow 2020–2025
Journey Medical Corp (DERM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.4MFY2025 · since FY2020: $5.1M → -$12.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.4M | -36.3% |
| FY2024 | -$9.1M | -274.2% |
| FY2023 | $5.2M | +138.7% |
| FY2022 | -$13.5M | -520.5% |
| FY2021 | -$2.2M | -142.5% |
| FY2020 | $5.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice